MTVA NASDAQ
MetaVia Inc.
1W: -7.2%
1M: -15.4%
3M: +2.0%
YTD: -83.9%
1Y: -86.4%
$1.54
+0.00 (+0.00%)
Weekly Expected Move ±7.5%
$1
$1
$2
$2
$2
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
7 relationships7
As Filer
counterparties named
0
As Counterparty
mentioned by others
3
Rel. Types
2022-09-14
Earliest Filing
2026-01-16
Latest Filing
partner: 4
supplier: 2
investor: 1
Counterparties (Filed by MTVA)
7 relationshipsCompanies named in MTVA's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Ladenburg Thalmann & Co. Inc. | — | partner | Entered into an underwriting agreement for the public offering of Class A and Class B Units. | 2026-01-16 | View |
| Equiniti Trust Company, LLC | — | partner | Appointed as warrant agent for the warrants issued in the public offering. | 2026-01-16 | View |
| Alewife Properties LLC | — | supplier | Landlord for new office space lease agreement | 2023-08-24 | View |
| 200 Berkeley Street Tenant LLC | — | supplier | Landlord of existing office space lease being terminated | 2023-08-24 | View |
| WeWork Inc. | — | partner | Affiliated entity of the landlord whose lease is being terminated | 2023-08-24 | View |
| Dong-A ST Co., Ltd. | — | investor | NeuroBo Pharmaceuticals amended Series A and Series B Warrants issued to Dong-A ST Co., Ltd. | 2023-04-14 | View |
| Dong-A ST Co., Ltd. | — | partner | Partnered with NeuroBo Pharmaceuticals for an exclusive license agreement, shared services, securities purchase, and inv | 2022-09-14 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-09 | Regulation FD; Other Events; Exhibits | View | |
| 2026-08-06 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-07-09 | Regulation FD; Other Events; Exhibits | View | |
| 2026-07-02 | Other Events; Exhibits | View | |
| 2026-06-08 | Regulation FD; Other Events; Exhibits | View | |
| 2026-06-08 | Officer/Director Change; Shareholder Vote; Exhibits | View | |
| 2026-05-27 | Regulation FD; Exhibits | View | |
| 2026-05-18 | Regulation FD; Exhibits | View | |
| 2026-04-10 | Regulation FD; Exhibits | View | |
| 2026-03-26 | Earnings Release; Exhibits | View | |
| 2026-03-26 | Regulation FD; Exhibits | View | |
| 2026-01-27 | Departure/Election of Directors; Appointment of Officers | View | |
| 2026-01-16 | Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits | Agreement | View |
| 2026-01-05 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2026-01-05 | Results of Operations and Financial Condition | View | |
| 2025-12-19 | Other Events | View | |
| 2025-12-02 | Material Modification to Rights of Security Holders; Amendments to Articles of Incorporation or Byla | View | |
| 2025-11-26 | Notice of Delisting or Transfer | View | |
| 2025-11-07 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-11-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR